Expression of the CTLA-4 ligand CD86 (B7.2) on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in chronic myeloid leukemia

Andreas Burchert, Christin Schütz, Susanne Saußele et al.|RWTH Publications (RWTH Aachen)|2016

Cited by 0